Cellectar Biosciences, Inc. (CLRB) Insider Trading Disclosures
Cellectar Biosciences, Inc. (CLRB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CLRB
CIK: 1279704
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMichael Lombardo
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001727492-26-000017 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-096766 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-096752 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003421 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001420506-26-001621 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | FORM 8-K | 0001104659-26-095460 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001104659-26-095426 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-04 | — | SCHEDULE 13G Filing | 0000919574-26-004748 | View SEC Doc Filr Page |
| 4/A | 2026-07-10 | 2026-07-08 | OWNERSHIP DOCUMENT | 0001104659-26-082761 | View SEC Doc Filr Page |
| 8-K | 2026-07-10 | 2026-07-07 | FORM 8-K | 0001104659-26-082719 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-082018 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-082016 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-082015 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-082014 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-082013 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-082012 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-082011 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-082010 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-08 | OWNERSHIP DOCUMENT | 0001104659-26-082009 | View SEC Doc Filr Page |
| 3 | 2026-06-09 | 2026-05-18 | OWNERSHIP DOCUMENT | 0001104659-26-071893 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-05 | — | SCHEDULE 13G Filing | 0001274173-26-000157 | View SEC Doc Filr Page |
| 424B3 | 2026-06-02 | — | 424B3 | 0001104659-26-069146 | View SEC Doc Filr Page |
| EFFECT | 2026-06-01 | — | EFFECT Filing | 9999999995-26-001826 | View SEC Doc Filr Page |
| CORRESP | 2026-05-29 | — | CORRESP Filing | 0001104659-26-067935 | View SEC Doc Filr Page |
| S-1/A | 2026-05-29 | — | FORM S-1/A | 0001104659-26-067933 | View SEC Doc Filr Page |